Phocas Financial Corp. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,367,000
+7.7%
75,213
-0.1%
0.64%
+14.4%
Q2 2023$4,053,000
+34.8%
75,285
-0.6%
0.56%
+28.8%
Q1 2023$3,007,000
-52.0%
75,704
-25.5%
0.43%
-42.8%
Q4 2019$6,263,000
-32.4%
101,567
-20.2%
0.75%
-23.8%
Q3 2019$9,270,000
-11.5%
127,200
-0.1%
0.99%
-11.8%
Q2 2019$10,472,000
+5.3%
127,391
-9.6%
1.12%
+12.0%
Q1 2019$9,945,000
+70.6%
140,977
+8.9%
1.00%
+53.8%
Q4 2018$5,829,000
+6.5%
129,476
+33.7%
0.65%
+35.4%
Q3 2018$5,473,000
+96.3%
96,805
+131.9%
0.48%
+100.0%
Q2 2018$2,788,00041,7410.24%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders